HUP0303655A2 - Proliferatív ileitis elleni hatékonyabb vakcinák, előállításuk és alkalmazásuk - Google Patents

Proliferatív ileitis elleni hatékonyabb vakcinák, előállításuk és alkalmazásuk

Info

Publication number
HUP0303655A2
HUP0303655A2 HU0303655A HUP0303655A HUP0303655A2 HU P0303655 A2 HUP0303655 A2 HU P0303655A2 HU 0303655 A HU0303655 A HU 0303655A HU P0303655 A HUP0303655 A HU P0303655A HU P0303655 A2 HUP0303655 A2 HU P0303655A2
Authority
HU
Hungary
Prior art keywords
intracellularis
proliferative ileitis
making
methods
same
Prior art date
Application number
HU0303655A
Other languages
English (en)
Original Assignee
Arizona Board Of Regents On Behalf Of The University Of Arizona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arizona Board Of Regents On Behalf Of The University Of Arizona filed Critical Arizona Board Of Regents On Behalf Of The University Of Arizona
Publication of HUP0303655A2 publication Critical patent/HUP0303655A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A találmány tárgyát általánosságban sertések Lawsonia intracellularisáltal okozott proliferatív ileitistől való megvédésére szolgálóvakcinák és diagnosztikumok előállítása képe. A találmány szerintiproliferatív ileitis elleni vakcinák tartalmazhatnak teljes L.intracellularis baktériumokat, L. intracellularis sejtkivonatokat,protektív L. intracellularis immunogén alegységeket rekombináns L.intracellularis immunogéneket, valamint csupasz L. intracellularisDNS-t. A találmány tárgyát képezik továbbá L. intracellularisnövekedését semlegesítő, valamint proliferatív ileitis diagnózisábanalkalmazható monoklonális antitestek is. Ó
HU0303655A 2000-09-29 2001-09-27 Proliferatív ileitis elleni hatékonyabb vakcinák, előállításuk és alkalmazásuk HUP0303655A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67710800A 2000-09-29 2000-09-29
PCT/US2001/030284 WO2002026250A2 (en) 2000-09-29 2001-09-27 Vaccines for proliferative ileitis

Publications (1)

Publication Number Publication Date
HUP0303655A2 true HUP0303655A2 (hu) 2004-03-01

Family

ID=24717358

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303655A HUP0303655A2 (hu) 2000-09-29 2001-09-27 Proliferatív ileitis elleni hatékonyabb vakcinák, előállításuk és alkalmazásuk

Country Status (7)

Country Link
US (1) US20060193874A1 (hu)
EP (1) EP1324768A2 (hu)
JP (1) JP2004529854A (hu)
AU (2) AU9315101A (hu)
CA (1) CA2423588A1 (hu)
HU (1) HUP0303655A2 (hu)
WO (1) WO2002026250A2 (hu)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0413857A (pt) * 2003-09-12 2006-10-24 Akzo Nobel Nv seqüência de ácido nucleico, fragmento de dna, molécula de dna recombinante, veìculo recombinante vivo, célula hispedeira, proteìna de lawsonia intracellularis, uso de uma proteìna de lawsonia intracellularis, vacina para combater infecções por lawsonia intracellularis, método para a preparação de uma vacina, e, teste diagnóstico
EP1709067B1 (en) * 2004-01-22 2010-06-09 Intervet International BV Lawsonia intracellularis subunit vaccines
MY146476A (en) 2004-06-24 2012-08-15 Boehringer Ingelheim Vetmed Method of diagnosing lawsonia intracellularis
EP1609870A1 (en) * 2004-06-24 2005-12-28 Boehringer Ingelheim Vetmedica Gmbh Method of diagnosing lawsonia intracellularis
US7550270B2 (en) * 2004-08-13 2009-06-23 Boehringer Ingelheim Vetmedica, Inc. Ileitis diagnostic assay
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US8470336B2 (en) 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
US20100129397A1 (en) 2006-12-11 2010-05-27 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
US8398970B2 (en) 2007-09-17 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Method of preventing early Lawsonia intracellularis infections
EP2205718A1 (en) * 2007-10-12 2010-07-14 Pfizer Inc. Methods of culturing lawsonia intracellularis
TWI449533B (zh) 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
TWI551295B (zh) 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
US8277650B2 (en) 2009-03-13 2012-10-02 Terrasep, Llc Methods and apparatus for centrifugal liquid chromatography
JP5977594B2 (ja) 2011-07-19 2016-08-24 住友化学株式会社 レジスト組成物及びレジストパターンの製造方法
EP3191576A4 (en) * 2014-09-12 2018-04-18 Anthrogenesis Corporation Methods for quantifying particulates in cell culture
JP2018504424A (ja) 2015-02-04 2018-02-15 インターベット インターナショナル ベー． フェー． 豚における無症候性ローソニア感染症に対する使用のためのワクチン
JP2018504423A (ja) 2015-02-04 2018-02-15 インターベット インターナショナル ベー． フェー． 豚における無症候性ローソニア感染症に対する使用のためのワクチン
EP3609533A1 (en) * 2017-04-13 2020-02-19 Intervet International B.V. Vaccines containing swine pathogens for associated non-mixed use
US10792352B2 (en) 2018-02-28 2020-10-06 Boehringer Ingelheim Vetmedica Gmbh Method for reducing skatole and/or indole in animals
CN110468088A (zh) * 2019-09-26 2019-11-19 华中农业大学 胞内劳森菌的培养方法及应用
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
AU2022375120A1 (en) 2021-11-01 2024-04-11 Boehringer Ingelheim Vetmedica Gmbh Immunogenic gel compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610059A (en) * 1992-11-09 1997-03-11 University Of Arizona Etiological agent for porcine enteritis
US5885823A (en) * 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
US5714375A (en) * 1995-06-05 1998-02-03 Nobl Laboratories, Inc. Ileal symbiont intracellularis propagation in suspended host cells
NZ322398A (en) * 1995-11-30 2000-02-28 Pig Res & Dev Corp Vaccine compositions comprising non-pathogenic form of Lawsonia intracellularis, nucleic acid sequences thereof and treatment of intestinal disease
JP2003521881A (ja) * 1999-05-13 2003-07-22 オーストラリアン ポーク リミティッド ローソニア由来の遺伝子及び関連ＯｍｐＨポリペプチド、ぺプチド及びタンパク質並びにそれらの使用
US6605696B1 (en) * 1999-10-22 2003-08-12 Pfizer, Inc. Lawsonia intracellularis proteins, and related methods and materials

Also Published As

Publication number Publication date
AU2001293151B2 (en) 2005-12-01
JP2004529854A (ja) 2004-09-30
WO2002026250A3 (en) 2003-05-01
CA2423588A1 (en) 2002-04-04
EP1324768A2 (en) 2003-07-09
WO2002026250A2 (en) 2002-04-04
US20060193874A1 (en) 2006-08-31
AU9315101A (en) 2002-04-08
AU2001293151B8 (en) 2006-01-12

Similar Documents

Publication Publication Date Title
HUP0303655A2 (hu) Proliferatív ileitis elleni hatékonyabb vakcinák, előállításuk és alkalmazásuk
NZ600584A (en) Anti-il 17a/il-17f cross-reactive antibodies and methods of use thereof
NZ594466A (en) Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies
AU3117201A (en) Methods and compositions for generating human monoclonal antibodies
MX2009005743A (es) Nuevos anticuerpos monoclonales de globulomero anti-ab selectivos del conformero ab.
UA93855C2 (ru) Вакцина, способствует росту, базирующейся ha нейтрализующем эпитопе
EP2371387A3 (en) HIV consensus sequence antigens and their use in vaccina
UA87665C2 (ru) Авирулентный изолят lawsonia intracellularis европейского происхождения, вакцина для иммунизации животных, применение заявленного авирулентного изолята как вакцины, способ получения вакцины, способ культивирования lawsonia intracellularis, способ диагностики пролиферативной энтеропатии свиней и способ получения антисыворотки к lawsonia intracellularis
YU28503A (sh) Humanizovana anti-lt-beta-r antitela
HK1143417A1 (en) Immune response assessment method
WO2004075850A3 (en) Polyvalent immunogen
HUP9903770A2 (hu) Eljárások és készítmények többepitópos antigének konformációjának megváltoztatására immunválasz kiváltása céljából
WO2004035742A3 (en) Sets of digital antibodies directed against short epitopes, and methods using same
HK1056292A1 (en) Method of culturing zooplankton, apparatus for culturing by the same, and culture obtained by the same.
DE60045870D1 (de) Monoklonaler antikörper, hybridoma, immuntestverfahren und diagnosekit
ATE477274T1 (de) Gegen clostridium difficile gerichtete antikörper
AU6720601A (en) Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof
DK1353688T3 (da) Fremgangsmåde og sammensætninger til immunisering med Psedomonas V-antigenet
EP1581638A4 (en) ANTIGENS P153 AND P156 FOR THE IMMUNODIAGNOSIS OF CANINE AND HUMAN EHRLICHIOSES AND USES THEREOF
DE60222296D1 (de) Impfstoff von umhüllten viren und verfahren zu seiner herstellung
WO2004032599A3 (en) Novel immunogenic proteins of leptospira
WO2008010098A3 (en) Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy
ATE370163T1 (de) Antikörper zur isolierung und/oder identifizierung mesenchymaler stammzellen und verfahren zur isolierung und/oder identifizierung mesenchymaler stammzellen
ATE348842T1 (de) Anti-pilyrosporum ovale igy und dessen verwendung
WO2005016952A3 (en) Polyvalent immunogen

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees